Shares of Alcentra Capital Corp (NASDAQ:ABDC) have earned an average recommendation of “Hold” from the seven ratings firms that are covering the company, Marketbeat.com reports. Three equities research analysts have rated the stock with a sell rating, one has given a hold rating, one has issued a buy rating and one has given a strong buy rating to the company. The average 12-month price objective among brokerages that have issued ratings on the stock in the last year is $12.25.

Several research firms have weighed in on ABDC. Rowe cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a report on Wednesday, November 8th. Raymond James Financial cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a report on Wednesday, November 8th. ValuEngine cut Alcentra Capital from a “buy” rating to a “hold” rating in a report on Friday, September 1st. UBS cut Alcentra Capital from an “outperform” rating to an “underperform” rating in a report on Wednesday, November 8th. Finally, Keefe, Bruyette & Woods reaffirmed a “hold” rating and issued a $9.50 price target on shares of Alcentra Capital in a research note on Friday, November 10th.

Shares of Alcentra Capital (NASDAQ ABDC) remained flat at $$8.32 during trading hours on Friday. 58,146 shares of the company’s stock were exchanged, compared to its average volume of 81,997. The stock has a market cap of $118.52, a P/E ratio of 5.58 and a beta of 0.62. Alcentra Capital has a fifty-two week low of $7.00 and a fifty-two week high of $14.73.

Alcentra Capital (NASDAQ:ABDC) last issued its earnings results on Monday, November 6th. The asset manager reported $0.34 EPS for the quarter, topping the consensus estimate of $0.33 by $0.01. Alcentra Capital had a positive return on equity of 11.32% and a negative net margin of 2.25%. The business had revenue of $7.61 million during the quarter. sell-side analysts anticipate that Alcentra Capital will post 1.29 EPS for the current year.

Alcentra Capital declared that its Board of Directors has initiated a share buyback plan on Monday, November 6th that authorizes the company to buyback $2.50 million in shares. This buyback authorization authorizes the asset manager to reacquire shares of its stock through open market purchases. Stock buyback plans are usually a sign that the company’s management believes its shares are undervalued.

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, January 4th. Shareholders of record on Friday, December 29th will be paid a dividend of $0.25 per share. This represents a $1.00 dividend on an annualized basis and a yield of 12.02%. The ex-dividend date of this dividend is Thursday, December 28th. Alcentra Capital’s payout ratio is -2,719.46%.

In related news, Director Steven H. Reiff purchased 6,900 shares of the business’s stock in a transaction on Monday, November 13th. The stock was acquired at an average price of $7.23 per share, with a total value of $49,887.00. Following the completion of the acquisition, the director now owns 35,246 shares of the company’s stock, valued at approximately $254,828.58. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, Director Paul J. Echausse sold 10,000 shares of the business’s stock in a transaction dated Thursday, November 9th. The shares were sold at an average price of $7.45, for a total value of $74,500.00. Following the sale, the director now directly owns 58,946 shares of the company’s stock, valued at approximately $439,147.70. The disclosure for this sale can be found here. Insiders bought 11,730 shares of company stock valued at $83,956 in the last 90 days. Company insiders own 4.96% of the company’s stock.

Hedge funds have recently modified their holdings of the business. Wasatch Advisors Inc. grew its stake in Alcentra Capital by 82.9% in the third quarter. Wasatch Advisors Inc. now owns 34,124 shares of the asset manager’s stock worth $365,000 after purchasing an additional 15,469 shares in the last quarter. Stephens Inc. AR bought a new stake in Alcentra Capital during the 3rd quarter valued at $253,000. Dynamic Technology Lab Private Ltd bought a new stake in Alcentra Capital during the 3rd quarter valued at $123,000. Spectrum Management Group Inc. bought a new stake in Alcentra Capital during the 3rd quarter valued at $107,000. Finally, Commerce Bank bought a new stake in Alcentra Capital during the 3rd quarter valued at $159,000. Institutional investors and hedge funds own 32.06% of the company’s stock.

ILLEGAL ACTIVITY WARNING: “Alcentra Capital Corp (ABDC) Receives $12.25 Consensus Target Price from Brokerages” was originally reported by TheOlympiaReport and is the property of of TheOlympiaReport. If you are accessing this piece on another publication, it was illegally copied and republished in violation of U.S. & international trademark and copyright laws. The original version of this piece can be viewed at https://theolympiareport.com/2017/12/06/alcentra-capital-corp-abdc-receives-12-25-consensus-target-price-from-brokerages.html.

About Alcentra Capital

Alcentra Capital Corporation is a specialty finance company that operates as a non-diversified, closed-end management investment company. The Company operates as a business development company and a regulated investment company. It provides customized debt and equity financing solutions to lower middle-market companies, which are companies having annual earnings, before interest, taxes, depreciation and amortization of between $5 million and $15 million, and/or revenues of between $10 million and $100 million.

Receive News & Ratings for Alcentra Capital Corp Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital Corp and related companies with Analyst Ratings Network's FREE daily email newsletter.